StockData
Progyny, Inc. logo

Progyny, Inc. (PGNY) stock

PGNYNasdaqServices-Misc Health & Allied Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 19/306% above fair value
$36.16−0.55 (-1.50%)

Close on Nov 18, 2026Market cap $2.77BP/E 39.3Yield –

Progyny free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Progyny's free cash flow for the twelve months ending Jun 30, 2026 was $178.38M, down 6.2% year over year. For fiscal 2025 it was $191.78M, up 10.4% from the year before. The highest annual figure on record is $191.78M in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$191.78M+10.4%
FY2024Dec 31, 2024$173.70M-6.2%
FY2023Dec 31, 2023$185.17M+140.0%
FY2022Dec 31, 2022$77.15M+222.7%
FY2021Dec 31, 2021$23.91M-32.0%
FY2020Dec 31, 2020$35.17M–
FY2019Dec 31, 2019-$4.49M-365.2%
FY2018Dec 31, 2018$1.69M–
FY2017Dec 31, 2017-$10.09M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$44.21M-12.0%
Q1 FY2026Mar 31, 2026$39.60M-15.7%
Q4 FY2025Dec 31, 2025$48.59M-3.3%
Q3 FY2025Sep 30, 2025$45.99M+7.6%
Q2 FY2025Jun 30, 2025$50.24M-10.0%
Q1 FY2025Mar 31, 2025$46.97M+88.8%
Q4 FY2024Dec 31, 2024$50.27M+35.9%
Q3 FY2024Sep 30, 2024$42.72M-19.7%
Q2 FY2024Jun 30, 2024$55.83M-25.8%
Q1 FY2024Mar 31, 2024$24.88M+26.2%
Q4 FY2023Dec 31, 2023$36.98M-27.2%
Q3 FY2023Sep 30, 2023$53.23M+170.8%
Q2 FY2023Jun 30, 2023$75.25M+301.2%
Q1 FY2023Mar 31, 2023$19.71M–
Q4 FY2022Dec 31, 2022$50.80M+519.2%
Q3 FY2022Sep 30, 2022$19.65M-16.2%
Q2 FY2022Jun 30, 2022$18.76M–
Q1 FY2022Mar 31, 2022-$12.05M-7493.9%
Q4 FY2021Dec 31, 2021$8.20M+27.4%
Q3 FY2021Sep 30, 2021$23.45M+54.4%
Q2 FY2021Jun 30, 2021-$7.90M-476.5%
Q1 FY2021Mar 31, 2021$163.00K-98.6%
Q4 FY2020Dec 31, 2020$6.44M–
Q3 FY2020Sep 30, 2020$15.18M+178.1%
Q2 FY2020Jun 30, 2020$2.10M-49.0%
Q1 FY2020Mar 31, 2020$11.45M–
Q4 FY2019Dec 31, 2019-$7.77M-298.2%
Q3 FY2019Sep 30, 2019$5.46M–
Q2 FY2019Jun 30, 2019$4.11M–
Q1 FY2019Mar 31, 2019-$6.30M–
Q4 FY2018Dec 31, 2018$3.92M–

More Progyny figures

See a number that looks wrong?